• 7486 Citations
1983 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed America’s first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohn’s, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devic’s, Myasthenia Gravis, Polymositis and Scleroderma

Certifications and Licenses

Internal Medicine
Hematology/Oncology

Training Experience

1987Residency, Baylor Affiliated Hospitals
1993Fellowship, National Institutes of Health

Education/Academic qualification

MD, Saint Louis University

… → 1984

Research interests

  • Autoimmune Diseases
  • Vascular Biology

Fingerprint Dive into the research topics where Richard K Burt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease

Burt, R. K., Craig, R., Yun, L., Halverson, A. L., Quigley, K., Arnautovic, I. & Han, X., Jan 1 2020, (Accepted/In press) In : Bone Marrow Transplantation.

Research output: Contribution to journalLetter

Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica

Burt, R. K., Balabanov, R., Han, X., Burns, C., Gastala, J., Jovanovic, B., Helenowski, I., Jitprapaikulsan, J., Fryer, J. P. & Pittock, S. J., Oct 29 2019, In : Neurology. 93, 18, p. E1732-E1741

Research output: Contribution to journalArticle

  • 4 Scopus citations

    Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

    Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., Fagius, J., Rose, J., Nelson, F., Barreira, A. A., Carlson, K., Han, X., Moraes, D., Morgan, A., Quigley, K., Yaung, K., Buckley, R., Alldredge, C., Clendenan, A., Calvario, M. A. & 3 others, Henry, J., Jovanovic, B. & Helenowski, I. B., Jan 15 2019, In : JAMA - Journal of the American Medical Association. 321, 2, p. 165-174 10 p.

    Research output: Contribution to journalArticle

  • 48 Scopus citations

    Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: Effect of conditioning regimen on outcome

    Burt, R. K., Han, X., Gozdziak, P., Yaung, K., Morgan, A., Clendenan, A. M., Henry, J., Calvario, M. A., Datta, S. K., Helenowski, I. & Schroeder, J., Jun 1 2018, In : Bone Marrow Transplantation. 53, 6, p. 692-700 9 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations

    News & views: Autologous HSCT is efficacious, but can we make it safer?

    Burt, R. K. & Farge, D., Mar 21 2018, In : Nature Reviews Rheumatology. 14, 4, p. 189-191 3 p.

    Research output: Contribution to journalArticle

    7 Scopus citations